Amarin Pharma, Inc. et al v. Hikma Pharmaceuticals USA Inc. et al
Mochida Pharmaceutical Co.,Ltd., Amarin Pharmaceuticals Ireland Limited and Amarin Pharma, Inc. |
Hikma Pharmaceuticals PLC., Hikma Pharmaceuticals USA Inc. and Health Net, LLC |
1:2020cv01630 |
November 30, 2020 |
US District Court for the District of Delaware |
Richard G Andrews |
Jennifer L Hall |
Patent |
35 U.S.C. § 271 |
Plaintiff |
Docket Report
This docket was last retrieved on January 4, 2022. A more recent docket listing may be available from PACER.
Document Text |
---|
Filing 20 OPENING BRIEF in Support re #19 MOTION to Dismiss for Failure to State a Claim, filed by Hikma Pharmaceuticals PLC., Hikma Pharmaceuticals USA Inc..Answering Brief/Response due date per Local Rules is 2/10/2021. (Gattuso, Dominick) Modified on 1/28/2021 (nms). |
Filing 19 MOTION to Dismiss for Failure to State a Claim - filed by Hikma Pharmaceuticals PLC., Hikma Pharmaceuticals USA Inc.. (Attachments: #1 Proposed Order)Motions referred to Jennifer L. Hall.(Gattuso, Dominick) Modified on 1/28/2021 (nms). |
Filing 18 SUMMONS Returned Executed by Amarin Pharmaceuticals Ireland Limited, Amarin Pharma, Inc., Mochida Pharmaceutical Co.,Ltd.. Health Net, LLC served on 1/26/2021, answer due 2/16/2021. (Anderson, Jeremy) |
Pro Hac Vice Attorney Claire A. Fundakowski for Hikma Pharmaceuticals PLC. and Hikma Pharmaceuticals USA Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd) |
Filing 17 First Amended Complaint for Patent Infringement against Hikma Pharmaceuticals PLC., Hikma Pharmaceuticals USA Inc., Health Net, LLC- filed by Amarin Pharmaceuticals Ireland Limited, Amarin Pharma, Inc., Mochida Pharmaceutical Co.,Ltd.. (Attachments: #1 Redline, #2 Exhibit A, #3 Exhibit B, #4 Exhibit C, #5 Exhibit D, #6 Exhibit E, #7 Exhibit F, #8 Exhibit G, #9 Exhibit H, #10 Exhibit I, #11 Exhibit J, #12 Exhibit K, #13 Exhibit L, #14 Exhibit M, #15 Exhibit N, #16 Exhibit O, #17 Exhibit P, #18 Exhibit Q, #19 Exhibit R, #20 Exhibit S, #21 Exhibit T, #22 Exhibit U, #23 Exhibit V, #24 Exhibit W, #25 Exhibit X, #26 Exhibit Y, #27 Exhibit Z, #28 Exhibit AA, #29 Exhibit BB, #30 Exhibit CC, #31 Exhibit DD, #32 Exhibit EE, #33 Exhibit FF, #34 Exhibit GG, #35 Exhibit HH, #36 Exhibit II)(Anderson, Jeremy) Modified on 1/26/2021 (nms). |
Filing 16 ORAL ORDER: The case is now referred to Magistrate Judge Jennifer L. Hall for all purposes through the case dispositive motion deadline. Ordered by Judge Richard G. Andrews on 1/13/2021. Motions referred to Jennifer L. Hall.(nms) |
Filing 15 STIPULATION to Extend Time - filed by Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited, Mochida Pharmaceutical Co.,Ltd.. (Anderson, Jeremy) Modified on 1/11/2021 (nms). |
SO ORDERED, re #15 STIPULATION to Extend Time (*Reset Briefing Schedule: re #11 MOTION to Dismiss. Answering Brief due 2/2/2021, Reply Brief due 2/16/2021). Signed by Judge Richard G. Andrews on 1/11/2021. (nms) |
Filing 14 MOTION for Pro Hac Vice Appearance of Attorney Eimeric Reig-Plessis of Winston & Strawn LLP - filed by Hikma Pharmaceuticals PLC., Hikma Pharmaceuticals USA Inc.. (Gattuso, Dominick) |
SO ORDERED, re #14 MOTION for Pro Hac Vice Appearance of Attorney Eimeric Reig-Plessis of Winston & Strawn LLP, filed by Hikma Pharmaceuticals USA Inc., Hikma Pharmaceuticals PLC.. Signed by Judge Richard G. Andrews on 1/5/2021. (nms) |
Pro Hac Vice Attorney Eimeric Reig-Plessis for Hikma Pharmaceuticals PLC. and Hikma Pharmaceuticals USA Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd) |
Filing 13 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Hikma Pharmaceuticals, PLC for Hikma Pharmaceuticals USA Inc. filed by Hikma Pharmaceuticals PLC., Hikma Pharmaceuticals USA Inc.. (Gattuso, Dominick) |
Filing 12 OPENING BRIEF in Support re #11 MOTION to Dismiss for Failure to State a Claim Under Fed. R. Civ. P. 12(B)(6), filed by Hikma Pharmaceuticals PLC., Hikma Pharmaceuticals USA Inc..Answering Brief/Response due date per Local Rules is 1/19/2021. (Gattuso, Dominick) Modified on 1/5/2021 (nms). |
Filing 11 MOTION to Dismiss for Failure to State a Claim Under Fed. R. Civ. P. 12(B)(6) - filed by Hikma Pharmaceuticals PLC., Hikma Pharmaceuticals USA Inc.. (Attachments: #1 Proposed Order)(Gattuso, Dominick) Modified on 1/5/2021 (nms). |
Pro Hac Vice Attorney Charles B. Klein for Hikma Pharmaceuticals PLC. and Hikma Pharmaceuticals USA Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd) |
SO ORDERED, re #10 MOTION for Pro Hac Vice Appearance of Attorney Charles B. Klein, Claire A. Fundakowski, and Alison M. Heydorn of Winston & Strawn LLP, filed by Hikma Pharmaceuticals USA Inc., Hikma Pharmaceuticals PLC.. Signed by Judge Richard G. Andrews on 12/9/2020. (nms) |
Filing 10 MOTION for Pro Hac Vice Appearance of Attorney Charles B. Klein, Claire A. Fundakowski, and Alison M. Heydorn of Winston & Strawn LLP - filed by Hikma Pharmaceuticals PLC., Hikma Pharmaceuticals USA Inc.. (Gattuso, Dominick) |
Filing 9 STIPULATION TO EXTEND TIME Answer to Complaint to February 22, 2021 - filed by Hikma Pharmaceuticals PLC., Hikma Pharmaceuticals USA Inc.. (Gattuso, Dominick) |
Filing 8 NOTICE of Appearance by Dominick T. Gattuso on behalf of Hikma Pharmaceuticals PLC., Hikma Pharmaceuticals USA Inc. (Gattuso, Dominick) |
Filing 7 Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Mochida Pharmaceutical Co.,Ltd.. (Anderson, Jeremy) |
Filing 6 Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate Amarin Corporation plc for Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited filed by Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited. (Anderson, Jeremy) |
SO ORDERED, re #9 STIPULATION and Order (*Reset Answer Deadlines: Hikma Pharmaceuticals PLC. answer due 2/22/2021; Hikma Pharmaceuticals USA Inc. answer due 2/22/2021). Signed by Judge Richard G. Andrews on 12/8/2020. (nms) |
Filing 5 SUMMONS Returned Executed by Amarin Pharmaceuticals Ireland Limited, Amarin Pharma, Inc., Mochida Pharmaceutical Co.,Ltd.. Hikma Pharmaceuticals USA Inc. served on 12/1/2020, answer due 12/22/2020. (Anderson, Jeremy) |
Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb) |
Filing 4 Summonses Issued (please complete the top portion of the form and print out for use/service). (apk) |
Filing 3 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 9,700,537 ;US 8,642,077 ;US 10,568,861. (apk) |
Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (apk) |
Filing 1 COMPLAINT filed with Jury Demand against Hikma Pharmaceuticals PLC., Hikma Pharmaceuticals USA Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number ADEDC-3364424.) - filed by Amarin Pharmaceuticals Ireland Limited, Amarin Pharma, Inc., Mochida Pharmaceutical Co.,Ltd.. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D, #5 Exhibit E, #6 Exhibit F, #7 Exhibit G, #8 Exhibit H, #9 Exhibit I, #10 Exhibit J, #11 Exhibit K, #12 Exhibit L, #13 Exhibit M, #14 Exhibit N, #15 Exhibit O, #16 Exhibit P, #17 Exhibit Q, #18 Exhibit R, #19 Exhibit S, #20 Exhibit T, #21 Exhibit U, #22 Exhibit V, #23 Exhibit W, #24 Exhibit X, #25 Exhibit Y, #26 Exhibit Z, #27 Exhibit AA, #28 Exhibit BB, #29 Civil Cover Sheet)(apk) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.